Skip to main content

Gelesis Holdings, Inc.

GLSHDelisted Apr 26, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001805087

Gelesis Holdings, Inc. was delisted on Apr 26, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 39 institutions reported holding it in 13F filings for Q1 2023, worth $3.55M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Gelesis Holdings, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of GLSH: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3839+1
Shares12.2M11.1M−1.12M (−9.2%)
Value$13.2M$3.22M−$9.96M (−75.6%)

New holders (6)

Institutions that held Gelesis Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to GLSH in Q4 2022
InstitutionSharesValue% of portfolio
Caz Investments LP100,000$29.0K0.09%
Renaissance Technologies LLC70,822$21.0K0.00%
Two Sigma Securities, LLC20,179$5.86K0.00%
Susquehanna International Group, LLP15,884$4.61K0.00%
UBS Group AG11,043$3.20K0.00%
Ameritas Investment Partners, Inc.739$2660.00%

Sold out (5)

Institutions that held Gelesis Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of GLSH in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Cormorant Asset Management, LP626,107$676.0K
Americana Partners, LLC52,684$56.0K
Goldman Sachs Group Inc16,472$18.0K
BNP Paribas Arbitrage, SA5,889$6.36K
Wells Fargo & Company113$0